findmyKOL

Marcelo Sampaio, MD

Basic profile

West Los Angeles College

ORCIDNPI
RegionLos Angeles, CA · WestSpecialtyNephrologyFocusNephrology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Marcelo Sampaio is a Nephrology physician affiliated with West Los Angeles College. OpenAlex indexes 50 publications with 1,781 citations (h-index 23).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
50publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,781citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

11301 Wilshire Blvd Bldg 500
Los Angeles, CA 900731003

Telephone

107-797-7203

Provider last certified this registry record 23 Dec 2021.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    66.8%
    Calcium channel blocker13.4%
    Amlodipine Besylate81%Diltiazem 24hr Er (Cd)19%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)11.9%
    Losartan Potassium100%
    Part D50 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    16.1%
    SGLT2 inhibitor6.9%
    Jardiance100%
    Part D33 patients
    Vitamin D3 Analog2.6%
    Calcitriol100%
    Part D14 patients

    + 5 more classes in this area

  • Other

    9%
    Phosphate Binder6.4%
    Sevelamer Carbonate100%
    Part D36 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia2.6%
    Lokelma59%Velphoro41%
    Part D<11 patients
Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”